The adherence of uropathogenic Escherichia coli (UPEC) to the host urothelial surface is the first step for establishing UPEC
infection.
Uroplakin Ia (UPIa), a
glycoprotein expressed on bladder urothelium, serves as a receptor for FimH, a
lectin located at bacterial pili, and their interaction initiates UPEC
infection.
Surfactant protein D (
SP-D) is known to be expressed on mucosal surfaces in various tissues besides the lung. However, the functions of
SP-D in the non-pulmonary tissues are poorly understood. The purposes of this study were to investigate the possible function of
SP-D expressed in the bladder urothelium and the mechanisms by which
SP-D functions.
SP-D was expressed in human bladder mucosa, and its
mRNA was increased in the bladder of the UPEC
infection model in mice.
SP-D directly bound to UPEC and strongly agglutinated them in a Ca(2+)-dependent manner. Co-incubation of
SP-D with UPEC decreased the bacterial adherence to 5637 cells, the human bladder cell line, and the UPEC-induced cytotoxicity. In addition, preincubation of
SP-D with 5637 cells resulted in the decreased adherence of UPEC to the cells and in a reduced number of cells injured by UPEC.
SP-D directly bound to UPIa and competed with FimH for UPIa binding. Consistent with the in vitro data, the exogenous administration of
SP-D inhibited UPEC adherence to the bladder and dampened UPEC-induced
inflammation in mice. These results support the conclusion that
SP-D can protect the bladder urothelium against UPEC
infection and suggest a possible function of
SP-D in urinary tract.